Aurobindo Pharma informs about press release

18 Nov 2022 Evaluate

Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Amphotericin B Liposome for Injection.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1177.10 8.20 (0.70%)
02-Feb-2026 15:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1629.00
Dr. Reddys Lab 1184.25
Cipla 1313.00
Zydus Lifesciences 877.15
Lupin 2124.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×